Pancreatic Neoplasm
68
17
17
32
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.3%
7 terminated out of 68 trials
82.1%
-4.5% vs benchmark
7%
5 trials in Phase 3/4
31%
10 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 32 completed trials
Clinical Trials (68)
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
Endoscopic Ultrasound Radiofrequency Ablation, Database Repository
MRE for Diagnosis of Pancreatic Masses
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
Delayed Gastric Emptying After Pancreatic Surgery
Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study